Company intelligence / Profile preview

Lazarus 3D

Philomath, Oregon, United States

Ownership: Private
Development stage: Commercial

Overview

Lazarus 3D’s Pre-Sure platform enables surgeons to rehearse patient-specific surgeries on ultra-realistic soft-tissue replicas derived from MR/CT data. The technology has received FDA clearance and has been adopted by leading US health systems to improve patient safety and outcomes in complex surgeries. No clinical trial results are reported as the product serves as a preoperative planning tool rather than a therapeutic intervention.

Therapeutic areas: Other
Modalities: Device (patient-specific soft-tissue surgical rehearsal models)
Industry: Surgical Medical Devices

Partnerships

Partnered with top US health systems for adoption of their technology in standard of care for complex surgeries

Beyond the preview

Go deeper on Lazarus 3D.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lazarus 3D.

Explore the full profile